A new trading day began on Friday, with Gossamer Bio Inc (NASDAQ: GOSS) stock price up 4.57% from the previous day of trading, before settling in for the closing price of $0.90. GOSS’s price has ranged from $0.46 to $1.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 77.55%. With a float of $186.93 million, this company’s outstanding shares have now reached $225.41 million.
The extent of productivity of a business whose workforce counts for 135 workers is very important to gauge. In terms of profitability, gross margin is 96.02%, operating margin of -67.61%, and the pretax margin is -74.46%.
Gossamer Bio Inc (GOSS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Gossamer Bio Inc is 17.37%, while institutional ownership is 66.60%. The most recent insider transaction that took place on Jun 24 ’24, was worth 1,260. In this transaction Chief Medical Officer of this company sold 1,908 shares at a rate of $0.66, taking the stock ownership to the 196,891 shares. Before that another transaction happened on Jun 21 ’24, when Company’s President & CEO bought 372,000 for $0.67, making the entire transaction worth $250,282. This insider now owns 5,408,073 shares in total.
Gossamer Bio Inc (GOSS) Latest Financial update
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.21 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 77.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.20% during the next five years compared to 11.99% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Here are Gossamer Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.40, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
The latest stats from [Gossamer Bio Inc, GOSS] show that its last 5-days average volume of 0.79 million was inferior to 1.47 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 44.80%. Additionally, its Average True Range was 0.06.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 50.74%, which indicates a significant increase from 43.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.21% in the past 14 days, which was lower than the 86.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9441, while its 200-day Moving Average is $0.9386. Now, the first resistance to watch is $0.9794. This is followed by the second major resistance level at $1.0178. The third major resistance level sits at $1.0721. If the price goes on to break the first support level at $0.8867, it is likely to go to the next support level at $0.8324. The third support level lies at $0.7940 if the price breaches the second support level.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
With a market capitalization of 212.91 million, the company has a total of 226,219K Shares Outstanding. Currently, annual sales are 0 K while annual income is -179,820 K. The company’s previous quarter sales were 95,840 K while its latest quarter income was 49,230 K.
